Suggestions
Alexis Burckhardt
Senior executive | Transformation Leadership | Global Marketing, P&L Operations & Digital | Pharma, Healthcare, Healthtech
Alexis Burckhardt is a senior executive at Novartis Oncology, holding the position of VP, Global Head Digital Transformation (Data & Digital, Customer Experience).2 Based in Basel, Switzerland, Burckhardt plays a crucial role in leading digital and customer experience transformation initiatives for the company.3
Professional Background
Burckhardt has extensive experience in the pharmaceutical industry, particularly in digital transformation and data-driven strategies. At Novartis Oncology, she is responsible for overseeing global efforts related to data, digital technologies, and enhancing customer experience.
Expertise and Contributions
Alexis Burckhardt is recognized for her expertise in:
- Digital transformation in the pharmaceutical sector
- Data-driven strategies
- Customer experience optimization
- Digital and data leadership in oncology
Her role involves spearheading initiatives that leverage data and digital technologies to improve patient outcomes and streamline operations within Novartis Oncology.1
Industry Recognition
Burckhardt's contributions to the field have been acknowledged in various industry forums. For instance, she was invited as a keynote speaker at the 2021 Pharmaceutical Management Science Association Conference, where she presented on "A New Era in Pharma: Data & Digital".4 This highlights her thought leadership in the digital transformation of the pharmaceutical industry.
Professional Network
As a senior executive in a global pharmaceutical company, Alexis Burckhardt has built an extensive professional network. Her LinkedIn profile indicates she has over 500 connections, suggesting a broad reach within the industry.3
Alexis Burckhardt's role at Novartis Oncology positions her at the forefront of digital innovation in the pharmaceutical sector, particularly in oncology. Her work likely involves integrating cutting-edge technologies and data-driven approaches to enhance patient care, research, and business operations in the field of cancer treatment.